Abstract |
Critically ill COVID-19 patients are generally admitted to the ICU for respiratory insufficiency which can evolve into a multiple-organ dysfunction syndrome requiring extracorporeal organ support. Ongoing advances in technology and science and progress in information technology support the development of integrated multi-organ support platforms for personalized treatment according to the changing needs of the patient. Based on pathophysiological derangements observed in COVID-19 patients, a rationale emerges for sequential extracorporeal therapies designed to remove inflammatory mediators and support different organ systems. In the absence of vaccines or direct therapy for COVID-19, extracorporeal therapies could represent an option to prevent organ failure and improve survival. The enormous demand in care for COVID-19 patients requires an immediate response from the scientific community. Thus, a detailed review of the available technology is provided by experts followed by a series of recommendation based on current experience and opinions, while waiting for generation of robust evidence from trials.
|
Authors | Claudio Ronco, Sean M Bagshaw, Rinaldo Bellomo, William R Clark, Faeq Husain-Syed, John A Kellum, Zaccaria Ricci, Thomas Rimmelé, Thiago Reis, Marlies Ostermann |
Journal | Blood purification
(Blood Purif)
2021
Vol. 50
Issue 1
Pg. 17-27
ISSN: 1421-9735 [Electronic] Switzerland |
PMID | 32454500
(Publication Type: Journal Article, Review)
|
Copyright | © 2020 S. Karger AG, Basel. |
Chemical References |
|
Topics |
- COVID-19
(blood, complications, therapy)
- Continuous Renal Replacement Therapy
(instrumentation, methods)
- Critical Illness
(epidemiology, therapy)
- Cytokines
(blood, isolation & purification)
- Equipment Design
- Extracorporeal Membrane Oxygenation
(instrumentation, methods)
- Hemoperfusion
(instrumentation, methods)
- Humans
- Multiple Organ Failure
(blood, etiology, therapy)
|